Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane p24 trafficking protein family member 8 (TMED8, FAM15B, L10) is a protein-coding gene in humans that has been listed as part of the TMED/p24 protein family. However, according to recent reviews, TMED8 is a GOLD domain-containing protein that, unlike true TMED/p24 family members, lacks a transmembrane domain and certain key conserved cysteine residues. As a result, TMED8 is not considered a bona fide p24/TMED family member and is incorrectly designated as such in several protein databases and literature sources[1][3]. Unlike canonical TMED family members, which are involved in protein sorting and vesicle trafficking in the early secretory pathway, the precise function, disease relevance, and therapeutic potential of TMED8 remain poorly defined. There is no evidence supporting its direct role as a receptor, transporter, or druggable target, and there are no established drugs, mechanisms, biomarkers, or safety issues related to TMED8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane emp24 protein transport domain-containing 8 (TMED8).